Natural and synthetic polymeric scaffolds

Biomedical Materials

Volumn , Issue , 2009, Pages 415-442

  Yoon, Diana M ^a   Fisher, John P ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885148586     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-84872-3_15     Document Type: Chapter

References (129)

1. Lee KY and Mooney DJ. Hydrogels for tissue engineering. Chem Rev, 2001a, 101(7):1869-1879.
2. Vinall RL, Lo SH, and Reddi AH. Regulation of articular chondrocyte phenotype by bone morphogenetic protein 7, interleukin 1, and cellular context is dependent on the cytoskeleton. Exp Cell Res, 2002, 272(1):32-44.
3. Hung CT, Lima EG, Mauck RL, Taki E, Le Roux MA, Lu HH, et al. Anatomically shaped osteochondral constructs for articular cartilage repair. J Biomech, 2003, 36(12):1853-1864.
4. Rahfoth B, Weisser J, Sternkopf F, Aigner T, Von der Mark K, and Brauer R. Transplantation of allograft chondrocytes embedded in agarose gel into cartilage defects of rabbits. Osteoarthr Cartil, 1998, 6(1):50-65.
5. Seal BL, Otero TC, and Panitch A. Polymeric biomaterials for tissue and organ regeneration. Mater Sci Eng R Rep, 2001, 34 (4-5):147-230.
6. Dillon GP, Yu X, Sridharan A, Ranieri JP, and Bellamkonda RV. The influence of physical structure and charge on neurite extension in a 3D hydrogel scaffold. J Biomater Sci Polym Ed, 1998, 9(10):1049-1069.
7. Wang L, Shelton RM, Cooper PR, Lawson M, Triffitt JT, and Barralet JE. Evaluation of sodium alginate for bone marrow cell tissue engineering. Biomaterials, 2003, 24(20):3475-3481.
8. Davis TA, Volesky B, and Mucci A. A review of the biochemistry of heavy metal biosorption by brown algae. Water Res, 2003, 37(18):4311-4330.
9. Rowley JA, Madlambayan G, and Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials, 1999, 20(1):45-53.
10. Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev, 2002, 54(1):3-12.
11. Shapiro L and Cohen S. Novel alginate sponges for cell culture and transplantation. Biomaterials, 1997, 18(8):583-590.
12. Guo JF, Jourdian GW, and MacCallum DK. Culture and growth characteristics of chondrocytes encapsulated in alginate beads. Connect Tissue Res, 1989, 19 (2-4):277-297.
13. Pariente JL, Kim BS, and Atala A. In vitro biocompatibility evaluation of naturally derived and synthetic biomaterials using normal human bladder smooth muscle cells. J Urol, 2002, 167(4):1867-1871.
14. Shimizu T, Yamato M, Kikuchi A, and Okano T. Cell sheet engineering for myocardial tissue reconstruction. Biomaterials, 2003, 24(13):2309-2316.
15. Liu H, Lee YW, and Dean MF. Re-expression of differentiated proteoglycan phenotype by dedifferentiated human chondrocytes during culture in alginate beads. Biochim Biophys Acta, 1998, 1425(3):505-515.
16. Glicklis R, Shapiro L, Agbaria R, Merchuk JC, and Cohen S. Hepatocyte behavior within three-dimensional porous alginate scaffolds. Biotechnol Bioeng, 2000, 67(3):344-353.
17. Mosahebi A, Simon M, Wiberg M, and Terenghi G. A novel use of alginate hydrogel as Schwann cell matrix. Tissue Eng, 2001, 7(5):525-534.
18. Leach JB, Bivens KA, Patrick CW, and Schmidt CE. Photocrosslinked hyaluronic acid hydrogels: Natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng, 2003, 82(5):578-589.
19. Hayashi T. Biodegradable polymers for biomedical uses. Prog Polym Sci, 1994, 19(4):663-702.
20. Aigner J, Tegeler J, Hutzler P, Campoccia D, Pavesio A, Hammer C, et al. Cartilage tissue engineering with novel nonwoven structured biomaterial based on hyaluronic acid benzyl ester. J Biomed Mater Res, 1998, 42(2):172-181.
21. Halbleib M, Skurk T, De Luca C, Von Heimburg D, and Hauner H. Tissue engineering of white adipose tissue using hyaluronic acid-based scaffolds. I: in vitro differentiation of human adipocyte precursor cells on scaffolds. Biomaterials, 2003, 24(18):3125-3132.
22. Vande Vord PJ, Matthew H W T, De Silva SP, Mayton L, Wu B, and Wooley PH. Evaluation of the biocompatibility of a chitosan scaffold in mice. J Biomed Mater Res, 2002, 59(3):585-590.
23. Suh J K F and Matthew H W T. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials, 2000, 21(24):2589-2598.
24. Li J, Pan J, Zhang L, Guo X, and Yu Y. Culture of primary rat hepatocytes within porous chitosan scaffolds. J Biomed Mater Res, 2003, 67 A (3):938-943.
25. Kawase M, Michibayashi N, Nakashima Y, Kurikawa N, Yagi K, and Mizoguchi T. Application of glutaraldehyde-crosslinked chitosan as a scaffold for hepatocyte attachment. Biol Pharm Bull, 1997, 20(6):708-710.
26. Seol YJ, Lee JY, Park YJ, Lee YM, Ku Y, Rhyu IC, et al. Chitosan sponges as tissue engineering scaffolds for bone formation. Biotechnol Lett, 2004, 26(13):1037-1041.
27. Nettles DL, Elder SH, and Gilbert JA. Potential use of chitosan as a cell scaffold material for cartilage tissue engineering. Tissue Eng, 2002, 8(6):1009-1016.
28. Lee CH, Singla A, and Lee Y. Biomedical applications of collagen. Int J Pharm, 2001b, 221 (1-2):1-22.
29. Drury JL and Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials, 2003, 24(24):4337-4351.
30. Ma L, Gao C, Mao Z, Shen J, Hu X, and Han C. Thermal dehydration treatment and glutaraldehyde cross-linking to increase the biostability of collagen-chitosan porous scaffolds used as dermal equivalent. J Biomater Sci Polym Ed, 2003, 14(8):861-874.
31. Langer R and Vacanti JP. Tissue engineering. Science, 1993, 260(5110):920-926.
32. Falanga V, Margolis D, Alvarez O, Auletta M, Maggiacomo F, Altman M, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol, 1998, 134(3):293-300.
33. Noah EM, Chen J, Jiao X, Heschel I, and Pallua N. Impact of sterilization on the porous design and cell behavior in collagen sponges prepared for tissue engineering. Biomaterials, 2002, 23(14):2855-2861.
34. Nehrer S, Breinan HA, Ramappa A, Hsu HP, Minas T, Shortkroff S, et al. Chondrocyteseeded collagen matrices implanted in a chondral defect in a canine model. Biomaterials, 1998, 19(24):2313-2328.
35. Risbud MV, Karamuk E, Schlosser V, and Mayer J. Hydrogel-coated textile scaffolds as candidate in liver tissue engineering: II. Evaluation of spheroid formation and viability of hepatocytes. J Biomater Sci-Polym Ed, 2003, 14(7):719-731.
36. Orwin EJ and Hubel A. In vitro culture characteristics of corneal epithelial, endothelial, and keratocyte cells in a native collagen matrix. Tissue Eng, 2000, 6(4):307-319.
37. Payne RG, Yaszemski MJ, Yasko AW, and Mikos AG. Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 1. Encapsulation of marrow stromal osteoblasts in surface crosslinked gelatin microparticles. Biomaterials, 2002, 23(22):4359-4371.
38. Awad HA, Wickham MQ, Leddy HA, Gimble JM, and Guilak F. Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds. Biomaterials, 2004, 25(16):3211-3222.
39. Risbud M, Endres M, Ringe J, Bhonde R, and Sittinger M. Biocompatible hydrogel supports the growth of respiratory epithelial cells: possibilities in tracheal tissue engineering. J Biomed Mater Res, 2001, 56(1):120-127.
40. Altman GH, Diaz F, Jakuba C, Calabro T, Horan RL, Chen J, et al. Silk-based biomaterials. Biomaterials, 2003, 24(3):401-416.
41. Minoura N, Aiba S, Gotoh Y, Tsukada M, and Imai Y. Attachment and growth of cultured fibroblast cells on silk protein matrices. J Biomed Mater Res, 1995, 29(10):1215-1221.
42. Sofia S, McCarthy MB, Gronowicz G, and Kaplan DL. Functionalized silk-based biomaterials for bone formation. J Biomed Mater Res, 2001, 54(1):139-148.
43. Middleton JC and Tipton AJ. Synthetic biodegradable polymers as orthopedic devices. Biomaterials, 2000, 21(23):2335-2346.
44. Thomson RC, Wake MC, Yaszemski MJ, and Mikos AG. Biodegradable polymer scaffolds to regenerate organs. Biopolymers II, 1995, 122:245-274.
45. Gunatillake PA and Adhikari R. Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater, 2003, 5:1-16; discussion 16.
46. Yang S, Leong KF, Du Z, and Chua CK. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng, 2001, 7(6):679-689.
47. Freed LE, Marquis JC, Nohria A, Emmanual J, Mikos AG, and Langer R. Neocartilage formation invitro and invivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res, 1993, 27(1):11-23.
48. Shinoka T, Ma PX, Shum-Tim D, Breuer CK, Cusick RA, Zund G, et al. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation, 1996, 94 (9) Suppl II: 164-168.
49. Kaihara S, Kim S, Kim BS, Mooney DJ, Tanaka K, and Vacanti JP. Survival and function of rat hepatocytes cocultured with nonparenchymal cells or sinusoidal endothelial cells on biodegradable polymers under flow conditions. J Pediatr Surg, 2000, 35(9):1287-1290.
50. Mooney DJ, Mazzoni CL, Breuer C, McNamara K, Hern D, Vacanti JP, et al. Stabilized polyglycolic acid fibre-based tubes for tissue engineering. Biomaterials, 1996a, 17(2):115-124.
51. Agrawal CM and Ray RB. Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J Biomed Mater Res, 2001, 55(2):141-150.
52. Ishaug-Riley SL, Okun LE, Prado G, Applegate MA, and Ratcliffe A. Human articular chondrocyte adhesion and proliferation on synthetic biodegradable polymer films. Biomaterials, 1999, 20 (23-24):2245-56.
53. Park SS, Jin HR, Chi DH, and Taylor RS. Characteristics of tissue-engineered cartilage from human auricular chondrocytes. Biomaterials, 2004, 25(12):2363-2369.
54. Yang F, Murugan R, Ramakrishna S, Wang X, Ma YX, and Wang S. Fabrication of nanostructured porous PLLA scaffold intended for nerve tissue engineering. Biomaterials, 2004, 25(10):1891-1900.
55. El-Amin SF, Lu HH, Khan Y, Burems J, Mitchell J, Tuan RS, et al. Extracellular matrix production by human osteoblasts cultured on biodegradable polymers applicable for tissue engineering. Biomaterials, 2003, 24(7):1213-1221.
56. Mooney DJ, Organ G, Vacanti JP, and Langer R. Design and fabrication of biodegradable polymer devices to engineer tubular tissues. Cell Transplant, 1994, 3(2):203-210.
57. Kim BS, Nikolovski J, Bonadio J, Smiley E, and Mooney DJ. Engineered smooth muscle tissues: regulating cell phenotype with the scaffold. Exp Cell Res, 1999, 251(2):318-328.
58. Teng YD, Lavik EB, Qu X, Park KI, Ourednik J, Zurakowski D, et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A, 2002, 99(5):3024-3029.
59. Dai NT, Williamson MR, Khammo N, Adams EF, and Coombes AG. Composite cell support membranes based on collagen and polycaprolactone for tissue engineering of skin. Biomaterials, 2004, 25(18):4263-4271.
60. Barralet JE, Wallace LL, and Strain AJ. Tissue engineering of human biliary epithelial cells on polyglycolic acid/polycaprolactone scaffolds maintains long-term phenotypic stability. Tissue Eng, 2003, 9(5):1037-1045.
61. Park YJ, Lee JY, Chang YS, Jeong JM, Chung JK, Lee MC, et al. Radioisotope carrying polyethylene oxide-polycaprolactone copolymer micelles for targetable bone imaging. Biomaterials, 2002, 23(3):873-879.
62. Ciapetti G, Ambrosio L, Savarino L, Granchi D, Cenni E, Baldini N, et al. Osteoblast growth and function in porous poly epsilon-caprolactone matrices for bone repair: a preliminary study. Biomaterials, 2003, 24(21):3815-3824.
63. Ng KW, Hutmacher DW, Schantz JT, Ng CS, Too HP, Lim TC, et al. Evaluation of ultrathin poly (epsilon-caprolactone) films for tissue-engineered skin. Tissue Eng, 2001, 7(4):441-455.
64. Fisher JP, Vehof JW, Dean D, Van der Waerden JP, Holland TA, Mikos AG, et al. Soft and hard tissue response to photocrosslinked poly (propylene fumarate) scaffolds in a rabbit model. J Biomed Mater Res, 2002, 59(3):547-56.
65. Fisher JP, Holland TA, Dean D, and Mikos AG. Photoinitiated cross-linking of the biodegradable polyester poly (propylene fumarate). Part II. In vitro degradation. Biomacromolecules, 2003, 4(5):1335-1342.
66. Peter SJ, Miller MJ, Yasko AW, Yaszemski MJ, and Mikos AG. Polymer concepts in tissue engineering. J Biomed Mater Res, 1998, 43(4):422-427.
67. Suggs LJ and Mikos AG. Development of poly (propylene fumarate-co-ethylene glycol) as an injectable carrier for endothelial cells. Cell Transplant, 1999, 8(4):345-350.
68. Shung AK, Behravesh E, Jo S, and Mikos AG. Crosslinking characteristics of and cell adhesion to an injectable poly (propylene fumarate-co-ethylene glycol) hydrogel using a watersoluble crosslinking system. Tissue Eng, 2003, 9(2):243-254.
69. Davis KA and Anseth KS. Controlled release from crosslinked degradable networks. Crit Rev Ther Drug Carrier Syst, 2002, 19 (4-5):385-423.
70. Heller J, Barr J, Ng SY, Abdellauoi KS, and Gurny R. Poly (ortho esters): Synthesis, characterization, properties and uses. Adv Drug Deliv Rev, 2002, 54(7):1039-1039.
71. Andriano KP, Tabata Y, Ikada Y, Heller J. In vitro and in vivo comparison of bulk and surface hydrolysis in absorbable polymer scaffolds for tissue engineering. J Biomed Mater Res, 1999, 48(5):602-612.
72. Vacanti JP, Morse MA, Saltzman WM, Domb AJ, Perez-Atayde A, and Langer R. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg, 1988, 23 (1 Pt 2):3-9.
73. Langer R. Biomaterials in drug delivery and tissue engineering: one laboratory's experience. Acc Chem Res, 2000, 33(2):94-101.
74. Kumar N, Langer RS, and Domb AJ. Polyanhydrides: an overview. Adv Drug Deliv Rev, 2002, 54(7):889-910.
75. Burkoth AK, Burdick J, and Anseth KS. Surface and bulk modifications to photocrosslinked polyanhydrides to control degradation behavior. J Biomed Mater Res, 2000a, 51(3):352-359.
76. Burkoth AK and Anseth KS. A review of photocrosslinked polyanhydrides: in situ forming degradable networks. Biomaterials, 2000b, 21(23):2395-2404.
77. Uhrich KE, Gupta A, Thomas TT, Laurencin CT, and Langer R. Synthesis and characterization of degradable poly (anhydride-co-imides). Macromolecules, 1995, 28(7):2184-2193.
78. Muggli DS, Burkoth AK, and Anseth KS. Crosslinked polyanhydrides for use in orthopedic applications: degradation behavior and mechanics. J Biomed Mater Res, 1999, 46(2):271-278.
79. Qiu LY and Zhu KJ. Novel biodegradable polyphosphazenes containing glycine ethyl ester and benzyl ester of amino acethydroxamic acid as cosubstituents: syntheses, characterization, and degradation properties. J Appl Polym Sci, 2000, 77(13):2987-2995.
80. Laurencin CT, Norman ME, Elgendy HM, El-Amin SF, Allcock HR, Pucher SR, et al. Use of polyphosphazenes for skeletal tissue regeneration. J Biomed Mater Res, 1993, 27(7):963-973.
81. Laurencin CT, El-Amin SF, Ibim SE, Willoughby DA, Attawia M, Allcock HR, et al. A highly porous 3-dimensional polyphosphazene polymer matrix for skeletal tissue regeneration. J Biomed Mater Res, 1996, 30(2):133-138.
82. Langone F, Lora S, Veronese FM, Caliceti P, Parnigotto PP, Valenti F, et al. Peripheral nerve repair using a poly (organo) phosphazene tubular prosthesis. Biomaterials, 1995, 16(5):347-353.
83. Tangpasuthadol V, Pendharkar SM, and Kohn J. Hydrolytic degradation of tyrosine-derived polycarbonates, a class of new biomaterials. Part I: Study of model compounds. Biomaterials, 2000, 21(23):2371-2378.
84. Choueka J, Charvet JL, Koval KJ, Alexander H, James KS, Hooper KA, et al. Canine bone response to tyrosine-derived polycarbonates and poly (L-lactic acid). J Biomed Mater Res, 1996, 31(1):35-41.
85. Lee SJ, Choi JS, Park KS, Khang G, Lee YM, and Lee HB. Response of MG63 osteoblastlike cells onto polycarbonate membrane surfaces with different micropore sizes. Biomaterials, 2004a, 25(19):4699-4707.
86. Cai J, Bo S, Cheng R, Jiang L, and Yang Y. Analysis of interfacial phenomena of aqueous solutions of polyethylene oxide and polyethylene glycol flowing in hydrophilic and hydrophobic capillary viscometers. J Colloid Interface Sci, 2004, 276(1):174-181.
87. Gutowska A, Jeong B, Jasionowski M. Injectable gels for tissue engineering. Anat Rec, 2001, 263(4):342-349.
88. Bourke SL and Kohn J. Polymers derived from the amino acid L-tyrosine: polycarbonates, polyarylates and copolymers with poly (ethylene glycol). Adv Drug Deliv Rev, 2003;55(4):447-466.
89. Novikova LN, Novikov LN, and Kellerth JO. Biopolymers and biodegradable smart implants for tissue regeneration after spinal cord injury. Curr Opin Neurol, 2003, 16(6):711-715.
90. Sawhney AS, Pathak CP, and Hubbell JA. Bioerodible hydrogels nased on photopolymerized poly (ethylene glycol)-co-poly (alpha-hydroxy acid) diacrylate macromers. Macromolecules, 1993, 26(4):581-587.
91. Sims CD, Butler PE, Casanova R, Lee BT, Randolph MA, Lee WP, et al. Injectable cartilage using polyethylene oxide polymer substrates. Plast Reconstr Surg, 1996, 98(5):843-850.
92. Bryant SJ and Anseth KS. Controlling the spatial distribution of ECMcomponents in degradable PEG hydrogels for tissue engineering cartilage. J Biomed Mater Res, 2003, 64 A (1):70-79.
93. Desai NP, Sojomihardjo A, Yao Z, Ron N, and Soon-Shiong P. Interpenetrating polymer networks of alginate and polyethylene glycol for encapsulation of islets of Langerhans. J Microencapsul, 2000, 17(6):677-690.
94. Ganta SR, Piesco NP, Long P, Gassner R, Motta LF, Papworth GD, et al. Vascularization and tissue infiltration of a biodegradable polyurethane matrix. J Biomed Mater Res, 2003, 64 A (2):242-248.
95. Gorna K and Gogolewski S. Preparation, degradation, and calcification of biodegradable polyurethane foams for bone graft substitutes. J Biomed Mater Res, 2003, 67 A (3):813-827.
96. Zhang J, Doll BA, Beckman EJ, and Hollinger JO. A biodegradable polyurethane-ascorbic acid scaffold for bone tissue engineering. J Biomed Mater Res, 2003, 67 A (2):389-400.
97. Grad S, Kupcsik L, Gorna K, Gogolewski S, and Alini M. The use of biodegradable polyurethane scaffolds for cartilage tissue engineering: potential and limitations. Biomaterials, 2003, 24(28):5163-5171.
98. McDevitt TC, Woodhouse KA, Hauschka SD, Murry CE, and Stayton PS. Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. J Biomed Mater Res, 2003, 66 A (3):586-595.
99. Sachlos E and Czernuszka JT. Making tissue engineering scaffolds work. Review: The application of solid freeform fabrication technology to the production of tissue engineering scaffolds. Eur Cell Mater, 2003, 5:29-39; discussion 39-40.
100. Mikos AG, Bao Y, Cima LG, Ingber DE, Vacanti JP, and Langer R. Preparation of poly (glycolic acid) bonded fiber structures for cell attachment and transplantation. J Biomed Mater Res, 1993, 27(2):183-189.
101. Mikos AG, Thorsen AJ, Czerwonka LA, Bao Y, Langer R, Winslow DN, et al. Preparation and characterization of poly (L-lactic acid) foams. Polymer, 1994, 35(5):1068-1077.
102. Hua FJ, Kim GE, Lee JD, Son YK, and Lee DS. Macroporous poly (L-lactide) scaffold 1. Preparation of a macroporous scaffold by liquid - liquid phase separation of a PLLA - dioxane - water system. J Biomed Mater Res, 2002, 63(2):161-167.
103. Ma PX and Zhang R. Synthetic nano-scale fibrous extracellular matrix. J BiomedMater Res, 1999, 46(1):60-72.
104. Nam YS and Park TG. Porous biodegradable polymeric scaffolds prepared by thermally induced phase separation. J Biomed Mater Res, 1999, 47(1):8-17.
105. Hsu YY, Gresser JD, Trantolo DJ, Lyons CM, Gangadharam PR, and Wise DL. Effect of polymer foam morphology and density on kinetics of in vitro controlled release of isoniazid from compressed foam matrices. J Biomed Mater Res, 1997, 35(1):107-116.
106. Whang K, Tsai DC, Nam EK, Aitken M, Sprague SM, Patel PK, et al. Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds. J Biomed Mater Res, 1998, 42(4):491-499.
107. Chen GP, Ushida T, and Tateishi T. Development of biodegradable porous scaffolds for tissue engineering. Mater Sci Eng C-Biomimetic Supramol Syst 2001;17(1-2):63-69.
108. Nam YS, Yoon JJ, and Park TG. A novel fabrication method of macroporous biodegradable polymer scaffolds using gas foaming salt as a porogen additive. J Biomed Mater Res, 2000, 53(1):1-7.
109. Mooney DJ, Baldwin DF, Suh NP, Vacanti JP, and Langer R. Novel approach to fabricate porous sponges of poly (D, L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials, 1996b, 17(14):1417-1422.
110. Sheridan MH, Shea LD, Peters MC, and Mooney DJ. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release, 2000, 64 (1-3):91-102.
111. Yang S, Leong KF, Du Z, and Chua CK. The design of scaffolds for use in tissue engineering. Part II. Rapid prototyping techniques. Tissue Eng, 2002, 8(1):1-11.
112. Hutmacher DW. Scaffold design and fabrication technologies for engineering tissues - state of the art and future perspectives. J Biomater Sci Polym Ed, 2001, 12(1):107-124.
113. Zein I, Hutmacher DW, Tan KC, and Teoh SH. Fused deposition modeling of novel scaffold architectures for tissue engineering applications. Biomaterials, 2002, 23(4):1169-1185.
114. Zeltinger J, Landeen LK, Alexander HG, Kidd ID, and Sibanda B. Development and characterization of tissue-engineered aortic valves. Tissue Eng, 2001, 7(1):9-22.
115. Cima LG, Vacanti JP, Vacanti C, Ingber D, Mooney D, and Langer R. Tissue engineering by cell transplantation using degradable polymer substrates. J Biomech Eng, 1991, 113(2):143-151.
116. Cooke MN, Fisher JP, Dean D, Rimnac C, Mikos AG. Use of stereolithography to manufacture critical-sized 3D biodegradable scaffolds for bone ingrowth. J Biomed Mater Res, 2003, 64 B (2):65-69.
117. Lu Y and Chen SC. Micro and nano-fabrication of biodegradable polymers for drug delivery. Adv Drug Deliv Rev, 2004, 56(11):1621-1633.
118. Angelova N and Hunkeler D. Rationalizing the design of polymeric biomaterials. Trends Biotechnol, 1999, 17(10):409-421.
119. Ma PX and Choi JW. Biodegradable polymer scaffolds with well-defined interconnected spherical pore network. Tissue Eng, 2001, 7(1):23-33.
120. Lee SH, Kim BS, Kim SH, Kang SW, and Kim YH. Thermally produced biodegradable scaffolds for cartilage tissue engineering. Macromol Biosci, 2004b, 4(8):802-810.
121. Lu L and Mikos AG. The importance of new processing techniques in tissue engineering. MRS Bull, 1996, 21(11):28-32.
122. Shin H, Jo S, and Mikos AG. Biomimetic materials for tissue engineering. Biomaterials, 2003, 24(24):4353-4364.
123. Holy CE, Fialkov JA, Davies JE, and Shoichet MS. Use of a biomimetic strategy to engineer bone. J Biomed Mater Res A, 2003, 65 A (4):447-453.
124. Cunliffe D, Pennadam S, and Alexander C. Synthetic and biological polymers-merging the interface. Eur Polym J, 2004, 40(1):5-25.
125. Shive MS and Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev, 1997, 28(1):5-24.
126. Ziats NP, Miller KM, and Anderson JM. In vitro and in vivo interactions of cells with biomaterials. Biomaterials, 1988, 9(1):5-13.
127. Anderson JM and Miller KM. Biomaterial biocompatibility and the macrophage. Biomaterials, 1984, 5(1):5-10.
128. Von Burkersroda F, Schedl L, and Gopferich A. Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials, 2002, 23(21):4221-4231.
129. Temenoff JS, Athanasiou KA, Le Baron RG, and Mikos AG. Effect of poly (ethylene glycol) molecular weight on tensile and swelling properties of oligo (poly (ethylene glycol) fumarate) hydrogels for cartilage tissue engineering. J Biomed Mater Res, 2002, 59(3):429-437.